Soll et al. V. Roepke et al. V. Soll et al.

29 Cited authorities

  1. Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.

    598 F.3d 1336 (Fed. Cir. 2010)   Cited 616 times   78 Legal Analyses
    Holding that our written description requirement requires that a specification “reasonably convey to those skilled in the art” that the inventor “actually invented” and “had possession of the claimed subject matter as of the filing date [of the invention]”
  2. Johnson Worldwide Assoc. v. Zebco Corp.

    175 F.3d 985 (Fed. Cir. 1999)   Cited 584 times
    Holding that "modifiers will not be added to broad terms standing alone"
  3. Allen Engineering v. Bartell Industries

    299 F.3d 1336 (Fed. Cir. 2002)   Cited 507 times   7 Legal Analyses
    Holding that claims that contradicted the specification were invalid as indefinite
  4. Personalized Media Comm. v. Int. T. Comm

    161 F.3d 696 (Fed. Cir. 1998)   Cited 523 times   5 Legal Analyses
    Holding that claim term “digital detector” recited sufficient structure to avoid § 112, ¶ 6
  5. Regents of the Univ. of Cal. v. Lilly & Co.

    119 F.3d 1559 (Fed. Cir. 1997)   Cited 333 times   17 Legal Analyses
    Holding that written description requires more than a "mere wish or plan for obtaining the claimed chemical invention"
  6. Lockwood v. American Airlines, Inc.

    107 F.3d 1565 (Fed. Cir. 1997)   Cited 305 times   6 Legal Analyses
    Holding that "[e]ach application in the chain must describe the claimed features" and that if "one of the intervening applications does not describe" the subject matter, the later application cannot claim the benefit of the earlier application
  7. In re Wands

    858 F.2d 731 (Fed. Cir. 1988)   Cited 345 times   43 Legal Analyses
    Holding that whether undue experimentation is required is a "conclusion reached by weighing many factual considerations. . . . includ[ing] the quantity of experimentation necessary, the amount of direction or guidance presented, the presence or absence of working examples, the nature of the invention, the state of the prior art, the relative skill of those in the art, the predictability or unpredictability of the art, and the breadth of the claims."
  8. ICU Medical, Inc. v. Alaris Medical Systems, Inc.

    558 F.3d 1368 (Fed. Cir. 2009)   Cited 179 times   8 Legal Analyses
    Finding that importing limitations from the specification into the claims may be proper where the specification "repeatedly and uniformly describes the spike as a pointed instrument for the purpose of piercing a seal inside the valve."
  9. Amgen, Inc. v. Chugai Pharmaceutical Co. LTD

    927 F.2d 1200 (Fed. Cir. 1991)   Cited 273 times   11 Legal Analyses
    Holding that the term "at least about" was indefinite because the patent provided no guidance as to where the line should be drawn between the numerical value of the prior art cited in the prosecution history and the close numerical value in the patent
  10. Gentry Gallery Inc. v. the Berkline Corp.

    134 F.3d 1473 (Fed. Cir. 1998)   Cited 211 times   4 Legal Analyses
    Holding that a claim “may be no broader than the supporting disclosure”
  11. Section 112 - Specification

    35 U.S.C. § 112   Cited 7,413 times   1065 Legal Analyses
    Requiring patent applications to include a "specification" that provides, among other information, a written description of the invention and of the manner and process of making and using it
  12. Section 135 - Derivation proceedings

    35 U.S.C. § 135   Cited 287 times   51 Legal Analyses
    Governing interferences
  13. Section 112 - Statutes at Large; contents; admissibility in evidence

    1 U.S.C. § 112   Cited 53 times
    Stating that the "Statutes at Large shall be legal evidence of laws"
  14. Section 11 - Exchange of copies of patents and applications with foreign countries

    35 U.S.C. § 11   Cited 16 times   1 Legal Analyses

    (a) IN GENERAL.-The Director may exchange copies of specifications and drawings of United States patents and published applications for patents for those of foreign countries. The Director shall not enter into an agreement to provide such copies of specifications and drawings of United States patents and applications to a foreign country, other than a USMCA country or a WTO member country, without the express authorization of the Secretary of Commerce. (b) DEFINITIONS.-In this section- (1) the term

  15. Section 90.1 - Scope

    37 C.F.R. § 90.1   Cited 2 times

    The provisions herein govern judicial review for Patent Trial and Appeal Board decisions under chapter 13 of title 35, United States Code. Judicial review of decisions arising out of inter partes reexamination proceedings that are requested under 35 U.S.C. 311 , and where available, judicial review of decisions arising out of interferences declared pursuant to 35 U.S.C. 135 continue to be governed by the pertinent regulations in effect on July 1, 2012. 37 C.F.R. §90.1